Vaccination in the Era of Covid – Touro College News
Posted: December 7, 2020 at 10:54 pm
Touro College of Osteopathic Medicine Middletown student Atif Towheed, Ph.D., is researching the health care provider's role in vaccination
Please can you share a couple of your top findings to date?
One of the most significant findings was the need for more education about vaccination. Respondents said this was a need they had for themselves as well as for their patients. We also confirmed the widespread belief that social media plays a critical role in patients decision-making when it comes to vaccines. Additionally, we learned that practitioners confidence levels in discussing vaccines with patients varied significantly between rural and urban areas, with more confidence in urban settings.
What are some of the key factors that pose barriers to vaccination?
Our research showed that key factors posing barriers to vaccination include lack of education on vaccines, fear of becoming sick after vaccination, parental or patient hesitancy, and safety concerns. There are ways to combat these barriers by increasing awareness through patient-provider interactions, including discussions about the risks and benefits of vaccines during patient interactions on routine visits. Based on these findings, we recommend an education program tiered to target health professionals at various levels of their education and careers.
How did you come to research this topic?
The study was initiated in summer 2019 after a noted outbreak of measles in and around our community. Our team of five includes faculty and students at TouroCOM, Middletown and a representative from the Orange County Department of Health. The work grew out of a discussion about the critical importance of vaccination for preventing illness. Under the supervision of Dr. Stephanie Zeszutek, clinical associate professor in the Department of Primary Care, we considered how vaccines also help lower health care costs, especially given the increasing number of vaccine-preventable diseases in the United States.
Others have looked into the relationship between vaccination rates and the education and views/beliefs of health care providers. How is your study different?
Most studies have focused specifically on patient populations. Although there are reports on health care providers views and beliefs, most of them are limited either to specific vaccines or to examining specific health care provider categories. Our study covers views and perspectives on most of the vaccines available in the U.S. We also have a very diverse survey population of health care workers and students.
Please share your background and how you became interested in science.
I was born and raised in India. My parents are both zoologists - my father is an endocrinologist, and I spent a lot of time in his lab learning from him. My mother is an assistant professor of sericulture (the study of silkworms). Their work made enough of an impression on me that I decided to pursue science; at the same time, I like to interact with people, so medical practice was always in the back of my mind.
After receiving my masters degree in biotechnology in India, I joined a U.N. research lab where I studied viruses, including the now-infamous SARS coronavirus. In 2009, I came to the U.S. to earn my Ph.D. at the University of Pittsburgh School of Medicine, after which I accepted a postdoctoral fellowship at The Childrens Hospital of Philadelphia (CHOP).During these years of research, I studied and evaluated gene therapy for mitochondrial diseases, including a potential treatment for Leber Hereditary Optic Neuropathy, an inherited form of vision loss.
How did you finally end up in medical school and at TouroCOM?
During my research and training, I was always associated with hospitals, collaborating with physicians, and talking about patients. I wanted to interact with patients directly, but the final decision to apply to medical school came when my son was born and suffered birth trauma. His doctor was a DO at CHOP, and her management of his care was holistic and inspiring, leading me to finally apply - and to DO schools. My wife often travels to New York City on business, so we wanted to find a school nearby. I attended an open house at TouroCOM and loved the school and the faculty. Im grateful to TouroCOM for giving me the chance to follow my passion.
See the rest here:
Vaccination in the Era of Covid - Touro College News
- After the Nobel, what next for Crispr gene-editing therapies? - The Guardian - February 25th, 2021
- Lucky winner! Rs 16 crore lottery gives new lease of life to 14-month-old Fatima - Zee Business - February 25th, 2021
- 14 Emerging Tech Trends for 2021and Dallas-Area Companies That Are Innovating for the Future Dallas Innovates - dallasinnovates.com - February 25th, 2021
- Gene Therapy - Cleveland Clinic - February 19th, 2021
- 14-month-old lottery winner with killer disease gets new life after expensive therapy in Bengaluru - India Today - February 17th, 2021
- 16 crore drug is the hope for SMA patients - The Hindu - February 14th, 2021
- The First Gene Based Project to be conducted in the Rio Grande Valley - Mega Doctor News - February 14th, 2021
- Spondyloarthritis: Types, symptoms, treatment, and more - Medical News Today - February 14th, 2021
- MSI-High and Colon Cancer: What It Means, Treatment Options, and More - Healthline - February 6th, 2021
- Targeted therapy for lung cancer: Side effects and more - Medical News Today - February 6th, 2021
- Baby can be saved from rare genetic disorder - but sister, 5, will die of it - Metro.co.uk - January 31st, 2021
- ALK Positive Lung Cancer: Life Expectancy, Survival, and More - Healthline - January 31st, 2021
- Dr. William Kelley inducted into IAOTPs Hall of Fame - PRUnderground - January 31st, 2021
- Last Call with Jenna Balestrini, the WPI grad treating cancer with cell therapy - Worcester Mag - January 14th, 2021
- Province gives family facing $2.8M drug bill a glimmer of hope - CBC.ca - January 14th, 2021
- New Combination Therapy Tested By Children's May Offer Hope For Leukemia Patients - WVXU - December 22nd, 2020
- This 6-year-old Iowa boy is losing his vision and hearing. But his family holds on to hope. - The Gazette - December 22nd, 2020
- What Is Gene Therapy? How Does It Work? | FDA - December 17th, 2020
- What is gene therapy? - The Star Online - December 17th, 2020
- What It's Like Rising A Little Boy With Advanced Breast Cancer - Oprah Mag - December 17th, 2020
- EAPM Advancing gene therapy with Advanced Therapy Medicinal Products - EU Reporter - December 16th, 2020
- San Diego's Locanabio raises $100 million for treatments aimed at degenerative diseases - The San Diego Union-Tribune - December 16th, 2020
- Italy needs new restrictions to avoid third, devastating COVID-19 wave - PM to paper - EU Reporter - December 16th, 2020
- Yes, men can get breast cancer here are the symptoms to watch for - Insider - INSIDER - December 12th, 2020
- Mumbai: Baby with genetic disorder needs Rs 16 crore therapy to live - Mid-day - December 12th, 2020
- Gene Therapy Liberates Hemophilia B Patients from Requiring Regular Infusions of Clotting Factor - MedicalResearch.com - December 12th, 2020
- Genentech Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Based Combination for People With Relapsed or Refractory Chronic... - December 7th, 2020
- Medicare and cystic fibrosis: Coverage, options, treatments, and costs - Medical News Today - December 7th, 2020
- The FDA has approved the first drug to treat the rapid-aging disease progeria - Science News - November 26th, 2020
- 'This is why I'm here': A Detroit Lions VP tries to save her daughter from rare disease - ESPN - November 24th, 2020
- Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG - OncoZine - November 24th, 2020
- SwanBio Therapeutics Expands Board of Directors with Appointments of Proven Industry Leaders - Business Wire - November 24th, 2020
- SwanBio Therapeutics Expands Board of Directors with Appointments of Proven Industry Leaders - BioSpace - November 23rd, 2020
- Rare Mutation in the PCSK9 Gene Confers Long Healthy Life - MedicalResearch.com - November 23rd, 2020
- Living through the second wave - Pakistan Today - November 23rd, 2020
- How two blind brothers became Two Blind Brothers for a cause - The Columbian - November 10th, 2020
- How two blind brothers created a one-of-a-kind shopping experience to raise money for a cure - WXII The Triad - November 10th, 2020
- The ethical way to alter organisms - The Boston Globe - November 10th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 10th, 2020
- Medical Milestone In Boston: 13-Year-Old Gets New Gene ... - November 5th, 2020
- How immunotherapy is revolutionizing cancer care - Genetic Literacy Project - October 29th, 2020
- The good news about breast cancer - The Gazette - October 29th, 2020
- Harris County parents win insurance appeal for 8-year-olds MD treatment - WRBL - October 29th, 2020
- Biohack the ageing process by taking care of this little protein in your body - Lifestyle Asia - October 22nd, 2020
- 'I have faith and I prayed a lot' - News from southeastern Connecticut - theday.com - October 22nd, 2020
- Piqray Improves Overall Survival for Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation - Breastcancer.org - October 20th, 2020
- Beating Cancer: Prevention must be 'cornerstone' of EU's new approach - The Parliament Magazine - October 20th, 2020
- Watch: New 5-minute injection a game-changer in breast cancer therapy in UAE - Gulf News - October 20th, 2020
- Homer Glen Mom and Nurse Breast Cancer-Free after Radiation Therapy Clinical Trial at UChicago Medicine Comprehensive Cancer Center at Silver Cross -... - October 20th, 2020
- Teenager among first to receive gene therapy treatment for rare condition - KRDO - October 8th, 2020
- Proposition 14: With Just Handful of Cures, California Stem Cell Agency's Fate Is In Hands of Voters - KQED - October 8th, 2020
- Teenager among first to receive gene therapy treatment for rare condition - NewsChannel 3-12 - KEYT - October 7th, 2020
- Greenbrier County teen to be among first in nation to receive gene therapy for Hurler's Syndrome - WVVA TV - October 7th, 2020
- Regenxbio RGX-121 Clinical Program, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha - October 7th, 2020
- Women In Longevity Medicine And The Rise Of The Longevity Physician - Forbes - October 7th, 2020
- Timothy Ray Brown, First Patient to Be Cured of HIV, Dies of Leukemia - BioSpace - October 7th, 2020
- Different Types of Childhood Cancer | INTEGRIS - Integris - October 4th, 2020
- Gene therapy company Taysha completes sprint from first funding to IPO - BioPharma Dive - September 26th, 2020
- Focused on the future: Innovative college programs in N.J. pave way for the real world - Jersey's Best - September 24th, 2020
- Burosumab Is a 'Game Changer,' Effective in All Subgroups of XLH - Medscape - September 22nd, 2020
- 10 Forgotten Spiderman Sidekicks They Need To Bring Back | CBR - CBR - Comic Book Resources - September 22nd, 2020
- Genentech Presents New Data From Multiple Phase III Studies of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020 - Business... - September 21st, 2020
- BCS Announces Partnership With 2nd.MD to Improve Member Healthcare Cost, Quality, and Outcomes - PRNewswire - September 19th, 2020
- Novus Therapeutics Announces Acquisition of Anelixis Therapeutics - Business Wire - September 19th, 2020
- Pace toddler wasn't supposed to survive. Thanks to wonder drug, parents say he's thriving - Pensacola News Journal - September 8th, 2020
- CRISPR can help combat the troubling immune response against gene therapy - The Conversation US - September 6th, 2020
- How Is Ovarian Cancer Diagnosed? Everything You Need To Know - NDTV Doctor - September 6th, 2020
- Genentech Announces FDA Approval of Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer |... - September 6th, 2020
- Gilmore Health: A Q&A Session on Genetic Diseases With Dr. Sony Sherpa - Gilmore Health News - September 6th, 2020
- Our teenage son is turning to stone and is becoming entombed in his own body - The Sun - August 28th, 2020
- Gene Therapy: IT Meets Medicine, But Who Is In Charge? - Walter Bradley Center for Natural and Artificial Intelligence - August 24th, 2020
- Edited Transcript of ISEE.OQ earnings conference call or presentation 5-Aug-20 12:00pm GMT - Yahoo Finance - August 6th, 2020
- Opinion: With any COVID-19 vaccine, humanity will face its biggest moral test - The Province - August 4th, 2020
- These Companies Are Seeking a Cure for Sickle Cell. And Its Just the Beginning for Some Gene Therapy Stocks. - Barron's - July 31st, 2020
- FDA Approves Combination Therapy for Treating Advanced Melanoma - Pharmacy Times - July 31st, 2020
- How Can Technology Help Fight the COVID-19 Pandemic? - IoT For All - July 31st, 2020
- Thomas Jefferson University doctor to be honored at W&J commencement - Observer-Reporter - July 30th, 2020
- First Edition: July 27, 2020 - Kaiser Health News - July 30th, 2020
- These are the most valued tech startups in France in 2020 - Silicon Canals - July 7th, 2020
- What's a life worth in dollars and cents? Should that influence who gets treated for expensive disease treatments? - Genetic Literacy Project - July 1st, 2020